Worthy Analytical Review for Endocyte, Inc. (NASDAQ:ECYT)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Endocyte, Inc. (NASDAQ:ECYT) for the period of 9-Day stands at 45.93% while the stochastic %D for the same period stands at 62.15%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Endocyte, Inc. (NASDAQ:ECYT) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Endocyte, Inc. (NASDAQ:ECYT) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Endocyte, Inc. (NASDAQ:ECYT)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based in West Lafayette, Indiana.

Previous Day Activity Analysis

On the last trading day, Endocyte, Inc. (NASDAQ:ECYT) opened the session at $4.36 and after going down -10.52% closed at $4.34. The stock lost -0.02 points in the last trade.

Endocyte, Inc. (NASDAQ:ECYT)’s stock fluctuated in the range of $4.21 and $4.58 during the previous active session. Endocyte, Inc. (NASDAQ:ECYT) traded with the volume of 1.88 Million with average volume of 2.84 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 1.78 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.51 and 62.76 respectively.

Currently the Insider Ownership of the shares of Endocyte, Inc. (NASDAQ:ECYT) is at 3.2% and the shares outstanding are 47.58 Million.

Important Ratio Analysis

Some important ratios to consider here for Endocyte, Inc. (NASDAQ:ECYT) are discussed below:

Dividend yield of Endocyte, Inc. (NASDAQ:ECYT) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 2949.96 and 1.59 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 1.74 and 0 correspondingly.

The Quick Ratio of Endocyte, Inc. (NASDAQ:ECYT) stands at 22.8 while the Current Ratio depicts the value of 22.8.

Return on Assets ROA of Endocyte, Inc. (NASDAQ:ECYT) is at -31.3% whereas, Return on Equity ROE and Return of Investment ROI of Endocyte, Inc. (NASDAQ:ECYT) stand at -32.7% and 0% respectively.

Stock Performance Analysis

The stock performance of Endocyte, Inc. (NASDAQ:ECYT) on the basis of 5 day trade show the dip of -24.52% whereas, the monthly performance of the stock shows increase of 203.5%.

The quarterly performance of the stock remained in green zone with the value of 195.24% while six month performance of the shares of Endocyte, Inc. (NASDAQ:ECYT) remained bullish with the count of 92.89%.

The yearly and YTD performance of Endocyte, Inc. (NASDAQ:ECYT) remained up at 45.15% and 70.2% respectively.